Michael H Ullmann Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 10 hours ago
Michael H Ullmann has an estimated net worth of at least $26.7 million*, as of yesterday. They own 158,834 shares of JNJ stock.
Michael H Ullmann $JNJ SEC Form 4 Insider Trading
Michael H Ullmann has filed a total of 0 insider trades in $JNJ since 2021. We estimate that they now own 158,834 shares of $JNJ, worth an estimated $26.7 million.
Insider Trading at $JNJ
There have been a total of 351 insider trades reported at $JNJ since 2021, with 1,000 shares purchased and 676,612 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 19,137 shares reported by JOHN C REED (EVP, Innovative Medicine, R&D), made on Jul 17, 2025.
History of Insider Stock Trades by Michael H Ullmann
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
| No Trades Available | - | - | - | - |
$JNJ Executives and Stock Owners with Insider Trades
-
Peter Fasolo, Exec VP, Chief HR Officer
-
Thibaut Mongon, Exec VP, WW Chair, Consumer
-
William Hait, See Remarks
-
Kathryn E Wengel, EVP, Chief GSC Officer
-
Joseph J Wolk, Exec VP, CFO
-
Robert J Decker, Controller, CAO
-
Ashley Mcevoy, EVP, WW Chair, MedTech
-
Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals
-
Robert J Decker, VP Corporate Controller
-
John C Reed, EVP, Innovative Medicine, R&D
-
James D. Swanson, See Remarks
-
Kathryn E Wengel, EVP, Chief TO and Risk Officer
-
Timothy Schmid, EVP, WW Chair, MedTech
-
Vanessa Broadhurst, EVP, Global Corp Affairs
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.